Literature DB >> 188860

High molecular weight forms of human ACTH are glycoproteins.

D N Orth, W E Nicholson.   

Abstract

The RIA-ACTH in a normal human pituitary, 2 ectopic ACTH-secreting tumors and plasma from a patient with Nelson's syndrome and one with ectopic ACTH syndrome was divided into 3 molecular weight classes after gel exclusion chromatography. The largest component appeared in or near the void volume and was designated "big" RIA-ACTH. The second, designated "intermediate" RIA-ACTH, eluted between the void volume and standard human 1-39 ACTH (mol. wt. 4,541). An immunoreactive material designated "little" ACTH-coeluted with standard human ACTH. A significant fraction (29-61%) of "big" RIA-ACTH from the tumors bound to concanavalin A-agarose and was eluted with 0.2 M alpha-methyl-D-mannopyranoside. An additional 16-22% of "big" RIA-ACTH was more tightly bound to the concanavalin A, but could be purged from the column with 0.1 M acetic acid. A smaller total percent of "big" RIA-ACTH from the pituitary (20%) and plasmas (5-10%) bound to the lectin and was similarly eluted and purged. Relatively little (less than 8%) of "intermediate" RIA-ACTH from all sources bound to concanavalin A, with the exception of that in the pitull sources was essentially excluded (greater than 93%) from the column. These data indicate that a significant fraction of human "big" RIA-ACTH is a glycoprotein and that human "intermediate" RIA-ACTH may be also.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188860     DOI: 10.1210/jcem-44-1-214

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Ectopic ACTH syndrome: clinicopathological correlations.

Authors:  W Singer; K Kovacs; N Ryan; E Horvath
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

2.  Corticotropin, lipotropin, and beta-endorphin production by a human nonpituitary tumor in culture: evidence for a common precursor.

Authors:  X Y Bertagna; W E Nicholson; G D Sorenson; O S Pettengill; C D Mount; D N Orth
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 3.  Corticotropin in human plasma. General considerations.

Authors:  M Schöneshöfer; H J Goverde
Journal:  Surv Immunol Res       Date:  1984

4.  Human placental immunoreactive corticotropin, lipotropin, and beta-endorphin: evidence for a common precursor.

Authors:  E Odagiri; B J Sherrell; C D Mount; W E Nicholson; D N Orth
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Biosynthesis in vitro of immunoreactive 31,000-dalton corticotropin/beta-endorphin-like material by bovine hypothalamus.

Authors:  A S Liotta; D Gildersleeve; M J Brownstein; D T Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene.

Authors:  T Tateno; M Kato; Y Tani; T Yoshimoto; Y Oki; Y Hirata
Journal:  J Endocrinol Invest       Date:  2009-09-11       Impact factor: 4.256

7.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  The nature of the immunoreactive lipotropins in human plasma and tissue extracts.

Authors:  K Tanaka; W E Nicholson; D N Orth
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.